We analysed TCGA database and found that patients with gastric cancer at stage IV expressed higher WNT5A mRNA expression compared with that at stage I (Supplementary Fig. S6), which indicates that WNT5A contributes to poorer prognosis and metastasis in patients with gastric cancer. The gene discussed is WNT5A; the disease is gastric cancer.